HEADER HYDROLASE/HYDROLASE INHIBITOR 25-MAY-22 8CZT TITLE STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH THE CYCLOPROPANE BASED TITLE 2 INHIBITOR 15D COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 GENE: ORF1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, MERS 3CL KEYWDS 2 PROTEASE INHHIBITORS, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.LIU,S.LOVELL,K.P.BATTAILE,H.N.NGUYEN,S.D.CHAMANDI,H.R.PICARD, AUTHOR 2 T.K.MADDEN,H.A.THRUMAN,Y.KIM,W.C.GROUTAS,K.O.CHANG REVDAT 5 25-OCT-23 8CZT 1 REMARK REVDAT 4 01-FEB-23 8CZT 1 JRNL REVDAT 3 11-JAN-23 8CZT 1 JRNL REVDAT 2 03-AUG-22 8CZT 1 TITLE JRNL REVDAT 1 22-JUN-22 8CZT 0 JRNL AUTH C.S.DAMPALLA,H.N.NGUYEN,A.D.RATHNAYAKE,Y.KIM,K.D.PERERA, JRNL AUTH 2 T.K.MADDEN,H.A.THURMAN,A.J.MACHEN,M.M.KASHIPATHY,L.LIU, JRNL AUTH 3 K.P.BATTAILE,S.LOVELL,K.O.CHANG,W.C.GROUTAS JRNL TITL BROAD-SPECTRUM CYCLOPROPANE-BASED INHIBITORS OF CORONAVIRUS JRNL TITL 2 3C-LIKE PROTEASES: BIOCHEMICAL, STRUCTURAL, AND VIROLOGICAL JRNL TITL 3 STUDIES. JRNL REF ACS PHARMACOL TRANSL SCI V. 6 181 2023 JRNL REFN ESSN 2575-910 JRNL PMID 36654747 JRNL DOI 10.1021/ACSPTSCI.2C00206 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 14919 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.610 REMARK 3 FREE R VALUE TEST SET COUNT : 688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.6900 - 3.5900 0.97 2914 137 0.1672 0.2046 REMARK 3 2 3.5900 - 2.8500 0.99 2942 127 0.2112 0.2918 REMARK 3 3 2.8500 - 2.4900 1.00 2907 161 0.2219 0.2813 REMARK 3 4 2.4900 - 2.2600 0.98 2884 137 0.2328 0.3235 REMARK 3 5 2.2400 - 2.1000 0.98 2584 126 0.2668 0.3387 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.930 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CZT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265777. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14941 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5WKK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG 3350, 100 MM BIS-TRIS, REMARK 280 200 MM AMMONIUM SULFATE, PH 5.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.80950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.46750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.80950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.46750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -18.99678 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 46.06681 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A 73 REMARK 465 ALA A 74 REMARK 465 PRO A 75 REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 ILE A 72 CG1 CG2 CD1 REMARK 470 ARG A 124 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 155 CE NZ REMARK 470 GLU A 156 CD OE1 OE2 REMARK 470 SER A 158 OG REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 GLN A 241 CD OE1 NE2 REMARK 470 GLN A 249 CG CD OE1 NE2 REMARK 470 GLN A 277 CD OE1 NE2 REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 MET A 298 CG SD CE REMARK 470 VAL A 304 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -128.92 53.02 REMARK 500 GLN A 48 15.70 -147.13 REMARK 500 ASP A 51 68.18 -150.79 REMARK 500 ALA A 220 21.77 -149.11 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8CZT A 1 306 UNP A0A1L2E0X0_9BETC DBREF2 8CZT A A0A1L2E0X0 3248 3553 SEQADV 8CZT MET A -6 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A -5 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A -4 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A -3 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A -2 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A -1 UNP A0A1L2E0X EXPRESSION TAG SEQADV 8CZT HIS A 0 UNP A0A1L2E0X EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER GLY LEU VAL LYS MET SEQRES 2 A 313 SER HIS PRO SER GLY ASP VAL GLU ALA CYS MET VAL GLN SEQRES 3 A 313 VAL THR CYS GLY SER MET THR LEU ASN GLY LEU TRP LEU SEQRES 4 A 313 ASP ASN THR VAL TRP CYS PRO ARG HIS VAL MET CYS PRO SEQRES 5 A 313 ALA ASP GLN LEU SER ASP PRO ASN TYR ASP ALA LEU LEU SEQRES 6 A 313 ILE SER MET THR ASN HIS SER PHE SER VAL GLN LYS HIS SEQRES 7 A 313 ILE GLY ALA PRO ALA ASN LEU ARG VAL VAL GLY HIS ALA SEQRES 8 A 313 MET GLN GLY THR LEU LEU LYS LEU THR VAL ASP VAL ALA SEQRES 9 A 313 ASN PRO SER THR PRO ALA TYR THR PHE THR THR VAL LYS SEQRES 10 A 313 PRO GLY ALA ALA PHE SER VAL LEU ALA CYS TYR ASN GLY SEQRES 11 A 313 ARG PRO THR GLY THR PHE THR VAL VAL MET ARG PRO ASN SEQRES 12 A 313 TYR THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS GLY SEQRES 13 A 313 SER VAL GLY TYR THR LYS GLU GLY SER VAL ILE ASN PHE SEQRES 14 A 313 CYS TYR MET HIS GLN MET GLU LEU ALA ASN GLY THR HIS SEQRES 15 A 313 THR GLY SER ALA PHE ASP GLY THR MET TYR GLY ALA PHE SEQRES 16 A 313 MET ASP LYS GLN VAL HIS GLN VAL GLN LEU THR ASP LYS SEQRES 17 A 313 TYR CYS SER VAL ASN VAL VAL ALA TRP LEU TYR ALA ALA SEQRES 18 A 313 ILE LEU ASN GLY CYS ALA TRP PHE VAL LYS PRO ASN ARG SEQRES 19 A 313 THR SER VAL VAL SER PHE ASN GLU TRP ALA LEU ALA ASN SEQRES 20 A 313 GLN PHE THR GLU PHE VAL GLY THR GLN SER VAL ASP MET SEQRES 21 A 313 LEU ALA VAL LYS THR GLY VAL ALA ILE GLU GLN LEU LEU SEQRES 22 A 313 TYR ALA ILE GLN GLN LEU TYR THR GLY PHE GLN GLY LYS SEQRES 23 A 313 GLN ILE LEU GLY SER THR MET LEU GLU ASP GLU PHE THR SEQRES 24 A 313 PRO GLU ASP VAL ASN MET GLN ILE MET GLY VAL VAL MET SEQRES 25 A 313 GLN HET P8L A 401 32 HETNAM P8L [(1~{S},2~{R})-2-CYCLOHEXYLCYCLOPROPYL]METHYL ~{N}- HETNAM 2 P8L [(2~{S})-1-[[(1~{R},2~{S})-1-[BIS(OXIDANYL)- HETNAM 3 P8L OXIDANYLIDENE-$L^{5}-SULFANYL]-1-OXIDANYL-3-[(3~{S})- HETNAM 4 P8L 2-OXIDANYLIDENEPYRROLIDIN-3-YL]PROPAN-2-YL]AMINO]-4- HETNAM 5 P8L METHYL-1-OXIDANYLIDENE-PENTAN-2-YL]CARBAMATE FORMUL 2 P8L C24 H42 N3 O8 S 1+ FORMUL 3 HOH *53(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 SER A 60 1 8 HELIX 5 AA5 THR A 62 PHE A 66 5 5 HELIX 6 AA6 CYS A 203 ASN A 217 1 15 HELIX 7 AA7 SER A 229 ALA A 239 1 11 HELIX 8 AA8 THR A 248 GLY A 259 1 12 HELIX 9 AA9 ALA A 261 THR A 274 1 14 HELIX 10 AB1 THR A 292 ILE A 300 1 9 SHEET 1 AA1 7 ASN A 77 LEU A 78 0 SHEET 2 AA1 7 SER A 67 GLN A 69 -1 N VAL A 68 O LEU A 78 SHEET 3 AA1 7 MET A 17 THR A 21 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 26 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N GLY A 82 O THR A 93 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 GLU A 169 1 O ILE A 160 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N THR A 154 O ASN A 161 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 GLU A 169 1 O ILE A 160 N THR A 105 SHEET 3 AA3 3 HIS A 175 SER A 178 -1 O SER A 178 N MET A 165 LINK SG CYS A 148 C14 P8L A 401 1555 1555 1.80 CRYST1 101.619 56.935 49.830 90.00 112.41 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009841 0.000000 0.004058 0.00000 SCALE2 0.000000 0.017564 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021708 0.00000